
TechCrunch: Microsoft’s Mustafa Suleyman says its AI outperforms doctors on hard cases as he chases ‘medical superintelligence’
Microsoft’s new AI diagnostic system beat generalist doctors on hard cases, according to a study in Science. But most of the improvement seems to come from the AI models underneath, not from Microsoft’s system itself.
Microsoft's AI diagnostic system, which coordinates multiple AI agents to question patients, order tests, and debate diagnoses, correctly identified complex medical cases 83 percent of the time in a simulation, compared to 36 percent for individual primary care doctors and general internists with reference materials. The company is working toward "medical superintelligence," defined as AI that can surpass human-led health systems in medical reasoning across full patient care. Microsoft is partnering with a Boston hospital to test this system in real-world emergency and urgent care settings, where patients receiving standard treatment will also be evaluated by the AI so its recommendations can be compared against human doctors' decisions. This effort joins similar work by other major AI companies in claiming their systems can match or outperform physicians in diagnostic tasks.
Want to go deeper than the news? Explore live, cohort-based AI courses taught by practitioners.
Browse AI courses on Maven
Microsoft AI chief Mustafa Suleyman. | Getty Images For years, AI leaders have touted healthcare as one of the clearest examples of where their technology will improve lives. Now "it is finally here," Microsoft AI CEO Mustafa Suleyman tells The Verge. The company claims to have developed an AI-powered tool it says can diagnose conditions up to four times more accurately than human doctors. The findings, published Thursday in one of the world's most prestigious journals, Science,

Anthropic's Claude independently designed protein binders targeting deadly scorpion neurotoxins. Out of more than 318,000 designs, 211 were tested in the lab. Seventeen met the criteria, and the two strongest bind extremely tightly to Cn2, a toxin from a Mexican scorpion. Whether they actually work as antivenom remains an open question. The article Claude Science tackles deadly scorpion stings by designing protein binders from scratch appeared first on The Decoder.
Also reported by The Verge
Diffusion language model startup Inception AI Inc. today released Mercury 3, its new flagship model. In the company’s own benchmarks, Mercury 3 beat OpenAI Group PBC’s GPT-6 Luna and Anthropic PBC’s Claude Haiku 5.5 on eight of 12 tests at four to eight times their speed. The release takes on the main doubt about Inception’s […] The post Inception says Mercury 3 beats GPT-6 Luna and Claude Haiku 5.5 at up to 8x the speed appeared first on SiliconANGLE.
Also reported by The Decoder

OpenAI's GPT-5.6 Sol discovered a critical PHP vulnerability as part of the Patch the Planet initiative that could affect millions of websites. Security firm Wiz independently found the same flaw using Google's Gemini 4 Argon. OpenAI warns that the same AI capabilities that find vulnerabilities can help attackers too. The article OpenAI's GPT-5.6 Sol and Google's Gemini 4 Argon found critical PHP flaw affecting millions of websites appeared first on The Decoder.
Also reported by TechCrunch

MiniMax's M3.1 Flash jumps 13 points over its predecessor to 42 on the Artificial Analysis Intelligence Index, at half the cost. It also hits 73.7 percent on the DeepSWE v1.1 coding benchmark for under $0.30 per task, matching Deepseek V4.1 Flash 1017 on both performance and price. The article MiniMax M3.1 Flash shows China's AI price race has no floor in sight appeared first on The Decoder.
Also reported by SiliconANGLE

Terminal X’s Eval Agent grades outputs against a 54-criterion rubric, catching 25% more deviances from a fund’s mandate with GPT-6.1 Sol.